Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 1
2007 1
2008 1
2009 1
2013 1
2015 4
2016 2
2017 7
2018 4
2019 9
2020 6
2021 8
2022 4
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma.
Capone E, Perrotti V, Cela I, Lattanzio R, Togni L, Rubini C, Caponio VCA, Lo Muzio L, Colasante M, Giansanti F, Ippoliti R, Iacobelli S, Wick MJ, Spardy Burr N, Sala G. Capone E, et al. Among authors: sala g. Oral Oncol. 2024 Jan;148:106635. doi: 10.1016/j.oraloncology.2023.106635. Epub 2023 Nov 21. Oral Oncol. 2024. PMID: 37988837 Free article.
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers.
Fracasso G, Falvo E, Tisci G, Sala G, Colotti G, Cingarlini S, Tito C, Bibbo S, Frusteri C, Tremante E, Giordani E, Giacomini P, Ceci P. Fracasso G, et al. Among authors: sala g. Heliyon. 2023 Oct 6;9(10):e20770. doi: 10.1016/j.heliyon.2023.e20770. eCollection 2023 Oct. Heliyon. 2023. PMID: 37860543 Free PMC article.
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET.
Keinänen O, Sarrett SM, Delaney S, Rodriguez C, Dayts EJ, Capone E, Sauniere F, Ippoliti R, Sala G, Iacobelli S, Zeglis BM. Keinänen O, et al. Among authors: sala g. Mol Pharm. 2023 Jun 5;20(6):3241-3248. doi: 10.1021/acs.molpharmaceut.3c00241. Epub 2023 May 16. Mol Pharm. 2023. PMID: 37191353 Free PMC article.
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer.
De Santis MC, Gozzelino L, Margaria JP, Costamagna A, Ratto E, Gulluni F, Di Gregorio E, Mina E, Lorito N, Bacci M, Lattanzio R, Sala G, Cappello P, Novelli F, Giovannetti E, Vicentini C, Andreani S, Delfino P, Corbo V, Scarpa A, Porporato PE, Morandi A, Hirsch E, Martini M. De Santis MC, et al. Among authors: sala g. Gut. 2023 Feb;72(2):360-371. doi: 10.1136/gutjnl-2021-325117. Epub 2022 May 27. Gut. 2023. PMID: 35623884 Free PMC article.
Breast cancer in the era of integrating "Omics" approaches.
Rossi C, Cicalini I, Cufaro MC, Consalvo A, Upadhyaya P, Sala G, Antonucci I, Del Boccio P, Stuppia L, De Laurenzi V. Rossi C, et al. Among authors: sala g. Oncogenesis. 2022 Apr 14;11(1):17. doi: 10.1038/s41389-022-00393-8. Oncogenesis. 2022. PMID: 35422484 Free PMC article. Review.
53 results